Table of Contents Author Guidelines Submit a Manuscript
Dermatology Research and Practice
Volume 2015, Article ID 236703, 4 pages
http://dx.doi.org/10.1155/2015/236703
Research Article

Clinical Features and Drug Characteristics of Patients with Generalized Fixed Drug Eruption in the West of Iran (2005–2014)

1Dermatology Department, Imam Reza Hospital, Kermanshah University of Medical Sciences (KUMS), Kermanshah 6714415333, Iran
2Health School, Family Health Research Center of Kermanshah University of Medical Sciences (KUMS), Kermanshah 6714415333, Iran
3Department of Pharmaceutics, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran
4Kermanshah University of Medical Sciences (KUMS), Kermanshah 6714415333, Iran

Received 30 September 2015; Accepted 1 December 2015

Academic Editor: Craig G. Burkhart

Copyright © 2015 Hossein Kavoussi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. M. Breathnach, “Drug reactions,” in Rook's Textbook of Dermatology, T. Burns, S. Breathnach, N. Cox, and C. Griffiths, Eds., pp. 28–177, Blackwell Science, Oxford, UK, 8th edition, 2010. View at Google Scholar
  2. Y. K. Heng, Y. W. Yew, D. S. Y. Lim, and Y. L. Lim, “An update of fixed drug eruptions in Singapore,” Journal of the European Academy of Dermatology and Venereology, vol. 29, no. 8, pp. 1539–1544, 2015. View at Publisher · View at Google Scholar
  3. J.-W. Jung, S.-H. Cho, K.-H. Kim, K.-U. Min, and H.-R. Kang, “Clinical features of fixed drug eruption at a tertiary hospital in Korea,” Allergy, Asthma and Immunology Research, vol. 6, no. 5, pp. 415–420, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. A.-Y. Lee, “Fixed drug eruptions. Incidence, recognition, and avoidance,” American Journal of Clinical Dermatology, vol. 1, no. 5, pp. 277–285, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Sawada, M. Nakamura, and Y. Tokura, “Generalized fixed drug eruption caused by pazufloxacin,” Acta Dermato-Venereologica, vol. 91, no. 5, pp. 600–601, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Can, E. Akkelle, B. Bay, Ö. Arıcan, Ö. Yalçın, and M. Yazicioglu, “Generalized fixed drug eruption in a child due to trimethoprim/sulfamethoxazole,” Pediatric Allergy and Immunology, vol. 25, no. 4, pp. 413–415, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Lipowicz, P. Sekula, S. Ingen-Housz-Oro et al., “Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis,” British Journal of Dermatology, vol. 168, no. 4, pp. 726–732, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. A. N. Ognongo-Ibiaho and H. L. Atanda, “Epidemiological study of fixed drug eruption in Pointe-Noire,” International Journal of Dermatology, vol. 51, supplement 1, pp. 30–31, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Mahboob and T. S. Haroon, “Drugs causing fixed eruptions: a study of 450 cases,” International Journal of Dermatology, vol. 37, no. 11, pp. 833–838, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. C.-H. Lee, Y.-C. Chen, Y.-T. Cho, C.-Y. Chang, and C.-Y. Chu, “Fixed-drug eruption: a retrospective study in a single referral center in northern Taiwan,” Dermatologica Sinica, vol. 30, no. 1, pp. 11–15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. W. B. Shelley and E. D. Shelley, “Nonpigmenting fixed drug eruption as a distinctive reaction pattern: examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozoline,” Journal of the American Academy of Dermatology, vol. 17, no. 3, pp. 403–407, 1987. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Özkaya-Bayazit, “Specific site involvement in fixed drug eruption,” Journal of the American Academy of Dermatology, vol. 49, no. 6, pp. 1003–1007, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Lawrentschuk, D. Pan, and A. Troy, “Fixed drug eruption of the penis secondary to sulfamethoxazole-trimethoprim,” TheScientificWorldJournal, vol. 6, pp. 2319–2322, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Saka, K. Kombaté, B.-H. Médougou et al., “Fixed drug eruption in dermatology setting in Lomé (Togo): a retrospective study of 321 cases,” Bulletin de la Societe de Pathologie Exotique, vol. 105, no. 5, pp. 384–387, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. V. K. Jain, V. B. Dixit, and Archana, “Fixed drug eruption of the oral mucous membrane,” Annals of Dentistry, vol. 50, no. 1, pp. 9–11, 1991. View at Google Scholar · View at Scopus
  16. N. Patro, M. Panda, M. Jena, and S. Mishra, “Multifocal fixed drug eruptions: a case series,” International Journal of Pharmaceutical Sciences Review and Research, vol. 23, no. 1, pp. 63–66, 2013. View at Google Scholar · View at Scopus
  17. J. Verbov, “Fixed drug eruption due to a drug combination but not to its constituents,” Dermatologica, vol. 171, no. 1, pp. 60–61, 1985. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Ohtoshi, Y. Kitami, H. Sueki, and T. Nakada, “Utility of patch testing for patients with drug eruption,” Clinical and Experimental Dermatology, vol. 39, no. 3, pp. 279–283, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Padmavathi, K. Manimekalai, and S. Ambujam, “Causality, severity and preventability assessment of adverse cutaneous drug reaction: a prospective observational study in a tertiary care hospital,” Journal of Clinical and Diagnostic Research, vol. 7, no. 12, pp. 2765–2767, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. V. N. Sehgal and G. Srivastava, “Fixed drug eruption (FDE): changing scenario of incriminating drugs,” International Journal of Dermatology, vol. 45, no. 8, pp. 897–908, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Sharma, D. Dogra, and N. Dogra, “A study of cutaneous adverse drug reactions at a tertiary center in Jammu, India,” Indian Dermatology Online Journal, vol. 6, no. 3, pp. 168–171, 2015. View at Publisher · View at Google Scholar
  22. S. R. Shukla, “Drugs causing fixed drug eruptions,” Dermatologica, vol. 163, no. 2, pp. 160–163, 1981. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Tohkin, A. Ishiguro, N. Kaniwa, Y. Saito, K. Kurose, and R. Hasegawa, “Prediction of severe adverse drug reactions using pharmacogenetic biomarkers,” Drug Metabolism and Pharmacokinetics, vol. 25, no. 2, pp. 122–133, 2010. View at Publisher · View at Google Scholar · View at Scopus